Exceptional early blood pressure control rates: the ACCOMPLISH trial
- PMID: 17612905
- DOI: 10.1080/08037050701395571
Exceptional early blood pressure control rates: the ACCOMPLISH trial
Abstract
Background: ACCOMPLISH is a "new-generation" hypertension trial assessing single-tablet combination therapy for initial treatment of high-risk hypertension. At baseline, 97% of subjects were treated with anti-hypertensive medication at entry, but only 37% of participants had blood pressure (BP) control (<140/90 mmHg). Single-tablet combination therapy may improve control rates.
Methods: The mean BP change from baseline at the end of 6 months (the time point when subjects should have had all of the drug titrations to achieve BP control) was examined for 10,704 randomized patients. Within-group changes were examined using t-tests. Comparisons between subgroups were made using analysis of variance (ANOVA) and covariance (ANCOVA).
Results: Mean (+/-SD) BP fell from 145+/-18/80+/-11 mmHg at randomization to 132+/-16/74+/-10 mmHg. The 6-month BP control rate was 73% in the overall trial (78% in the US), 43% in diabetics and 40% in patients with renal disease. Of the patients uncontrolled, 61% were not on maximal medications, suggesting potential increases in control rates. Serious hypotensive events occurred in 1.8% of participants.
Conclusion: ACCOMPLISH BP control rates are the highest of any multi-national trial to date. Whereas current guidelines recommend combination therapy only for stage 2 hypertension, in this trial it is expedient and safe for both stage 1 and 2 hypertension.
Similar articles
-
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.Blood Press. 2008;17(1):7-17. doi: 10.1080/08037050801972857. Blood Press. 2008. PMID: 18568687 Clinical Trial.
-
Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.Blood Press Monit. 2009 Jun;14(3):112-20. doi: 10.1097/MBP.0b013e32832a9da7. Blood Press Monit. 2009. PMID: 19384192 Clinical Trial.
-
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.Blood Press. 2012 Apr;21(2):82-7. doi: 10.3109/08037051.2011.598699. Epub 2011 Aug 10. Blood Press. 2012. PMID: 21830844 Clinical Trial.
-
Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.Clin Ther. 2007 Sep;29(9):1924-36. doi: 10.1016/j.clinthera.2007.09.018. Clin Ther. 2007. PMID: 18035192 Clinical Trial.
-
Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.Curr Med Res Opin. 2008 Aug;24(8):2389-401. doi: 10.1185/03007990802262457. Epub 2008 Jul 9. Curr Med Res Opin. 2008. PMID: 18616863 Review.
Cited by
-
Fixed-dosed combinations are not indicated as initial therapy: a debate.J Clin Hypertens (Greenwich). 2009 Feb;11(2):94-9. doi: 10.1111/j.1751-7176.2009.00078.x. J Clin Hypertens (Greenwich). 2009. PMID: 19222675 Free PMC article. No abstract available.
-
Combination therapy with Renin-Angiotensin-aldosterone receptor blockers for hypertension: how far have we come?J Clin Hypertens (Greenwich). 2008 Feb;10(2):146-52. doi: 10.1111/j.1751-7176.2008.07439.x. J Clin Hypertens (Greenwich). 2008. PMID: 18256579 Free PMC article. Review.
-
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.J Am Soc Hypertens. 2015 Sep;9(9):670-9. doi: 10.1016/j.jash.2015.06.012. Epub 2015 Aug 7. J Am Soc Hypertens. 2015. PMID: 26320890 Free PMC article.
-
Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial.Cardiol Ther. 2017 Jun;6(1):91-104. doi: 10.1007/s40119-017-0085-7. Epub 2017 Feb 8. Cardiol Ther. 2017. PMID: 28181192 Free PMC article.
-
The clock is ticking: the case for achieving more rapid control of hypertension.J Clin Hypertens (Greenwich). 2010 May;12(5):323-7. doi: 10.1111/j.1751-7176.2010.00274.x. J Clin Hypertens (Greenwich). 2010. PMID: 20546372 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical